 | Up a level |
Kovanda, Laura L 
ORCID: 0000-0002-4493-4652, Marty, Francisco M, Maertens, Johan, Desai, Amit V, Lademacher, Christopher, Engelhardt, Marc, Lu, Qiaoyang and Hope, William W ORCID: 0000-0001-6187-878X
(2017)
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (6).
e00101-e00117.
Kovanda, Laura L ORCID: 0000-0002-4493-4652, Desai, Amit V, Lu, Qiaoyang, Townsend, Robert W, Akhtar, Shahzad, Bonate, Peter and Hope, William W ORCID: 0000-0001-6187-878X
(2016)
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study).
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60 (8).
pp. 4568-4576.
Andes, David R, Ghannoum, Mahmoud A, Mukherjee, Pranab K, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Lu, Qiaoyang, Jones, Mark E, Henriksen, Anne Santerre, Lademacher, Christopher and Hope, William W ORCID: 0000-0001-6187-878X
(2019)
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (1).
e01634-e01618.